desonide

(redirected from Verdeso)
Also found in: Medical.
Related to Verdeso: Xolegel

des·o·nide

 (dĕs′ə-nīd′)
n.
A topical corticosteroid, C24H32O6, used to treat inflammatory disorders of the skin.

[de(lta) + (hydrocorti)son(e) + -ide.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
Ethanol-free desonide emulsion foam (Verdeso), developed by Connetics Corp., which funded the current study, is approved to treat mild to moderate atopic dermatitis (AD), said Dr.
Some of the newest and best-known Stiefel brands are Duac topical gel (clindamycin, 1% benzoyl peroxide, 5%) available in the Duac Care System; Evoclin (clindamycin phosphate) foam, 1%; Luxiq (betamethasone valerate) foam, 0.12%; MimyX cream; Olux (clobetasol propionate) foam, 0.05%, and Ohix-E (clobetasol propionate) foam, 0.05%, also available in the Olux/Olux-E complete pack; Soriatane (acitretin) capsules, available in the Soriatane CK convenience kit; Verdeso (desonide) foam, 0.05%; Brevoxyl-4 creamy wash (benzoyl peroxide 4%) and Brevoxyl-8 creamy wash (benzoyl peroxide 8%), packaged in the Brevoxyl acne wash kit; Extina (ketoconazole) foam, 2%; Oilatum cleansing bar; Physiogel cream; Stieprox (ciclopirox olamine) shampoo; Revaleskin skin care products; and Sarna lotion.
Three products have received Food and Drug Administration approval for use in patients aged as young as 3 months: desonide nonethanolic foam (Verdeso, Stiefel Laboratories Inc.); desonide aqueous gel (Desonate, Skin-Medica Inc.); and fluocinolone acetonide oil (Derma-Smoothe, Hill Dermaceuticals Inc.).
Three products have received Food and Drug Administration approval for use in patients as young as 3 months of age: desonide nonethanolic foam (Verdeso, Stiefel Laboratories Inc.); desonide aqueous gel (Desonate, SkinMedica Inc.); and fluocinolone acetonide oil (Derma-Smoothe, Hill Dermaceuticals Inc.).
A few weeks after the merger was announced, that product line got bigger when Connectics launched Verdeso Foam, a low-potency topical steroid for treating mild to moderate atopic dermatitis in children and adults.
The three topical steroids indicated for use down to 3 months of age are fluticasone 0.05% cream and desonide 0.05% gel (Desonate) and desonide 0.05% moisturizing foam (Verdeso).